-
August 25: The Week in Cancer News
Study finds association between lorazepam use and poorer cancer outcomes, and weight-loss surgery linked to lower cancer risk in women.
by Thomas Celona
-
August 18: The Week in Cancer News
Radiation therapy is falling out of favor for some cancer types, and concerns grow about commercially available multi-cancer detection tests.
by Eric Fitzsimmons
-
August 11: The Week in Cancer News
Research links testicular cancer in military firefighters to ‘forever chemicals,’ and older women who are screened for breast cancer at risk for overdiagnosis.
by Marci A. Landsmann
-
August 4: The Week in Cancer News
Genetic testing can help establish inherited cancer risk, and a new cancer registry tracks breast and prostate cancer in people of African origin.
by Kevin McLaughlin
-
July 28: The Week in Cancer News
Less than four minutes of physical activity per day linked to lower cancer risk, and vaccination helped improve outcomes for cancer patients with COVID-19.
by Thomas Celona
-
July 21: The Week in Cancer News
ASCO guideline emphasizes the importance of assessment for older cancer patients, and a change in mammogram recommendations reignites screening debates.
by Eric Fitzsimmons
-
July 14: The Week in Cancer News
Black men with melanoma have higher risk of dying, and CAR T-cell therapy provides hope for aggressive lymphoma.
by Marci A. Landsmann
-
July 7: The Week in Cancer News
Reducing cancer treatment to improve quality of life without lowering effectiveness, and death rates are climbing for certain cancers in Hispanic Americans.
by Kevin McLaughlin
-
June 30: The Week in Cancer News
Childhood cancer survivors have a higher risk of developing depression and anxiety, and study links polycystic ovary syndrome to higher ovarian cancer risk for postmenopausal women.
by Thomas Celona
-
June 23: The Week in Cancer News
New treatments have changed care for multiple myeloma, and as drug companies have moved away from producing generics, the U.S. runs into cancer drug shortages.
by Eric Fitzsimmons
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona